Coltene Holding AG's revenue for the
six
months ended in Dec. 2025 was CHF122.0 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was CHF240.0 Mil.
Coltene Holding AG's Revenue per Share for the
six
months ended in Dec. 2025 was CHF20.53.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF40.18.
Warning Sign:
Coltene Holding AG revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Coltene Holding AG was -4.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -3.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -1.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 0.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Coltene Holding AG's highest 3-Year average Revenue per Share Growth Rate was 6.30% per year. The lowest was -12.20% per year. And the median was 0.40% per year.
Coltene Holding AG (XSWX:CLTN) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Coltene Holding AG Revenue Related Terms
Coltene Holding AG Revenue Historical Data
* Premium members only.
The historical data trend for Coltene Holding AG's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Coltene Holding AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coltene Holding AG Revenue vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coltene Holding AG's Revenue distribution charts can be found below:
* The bar in red indicates where Coltene Holding AG's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF240.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coltene Holding AG (XSWX:CLTN) has a Revenue of CHF240.0 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Coltene Holding AG and its competitors.
Is Coltene Holding AG's Revenue too high?
Coltene Holding AG's current Revenue is CHF240.0 Mil. Overall, Coltene Holding AG has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's Revenue compare to ISRG and BDX?
Coltene Holding AG's Revenue of CHF240.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Coltene Holding AG and its competitors. Coltene Holding AG's current Revenue is CHF240.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Coltene Holding AG (XSWX:CLTN) is currently considered Fairly Valued. The stock's GF Value™ is CHF55.14, compared to a current price of CHF51.80 — trading 6.1% below its estimated fair value. The current Revenue is CHF240.0 Mil. Coltene Holding AG's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Coltene Holding AG (XSWX:CLTN), the current Revenue is CHF240.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coltene Holding AG (XSWX:CLTN) Overvalued in 2026?
Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued.
The current stock price of CHF51.80 is trading 6.1% below its estimated GF Value™ of CHF55.14.
GuruFocus considers Coltene Holding AG to be Fairly Valued.
Key valuation signals for XSWX:CLTN:
Revenue: CHF240.0 Mil
GF Value™: CHF55.14 vs. price of CHF51.80 (6.1% below fair value)
No single metric tells the full story. See the XSWX:CLTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
67GF Score
Get the complete analysis for XSWX:CLTN
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CLTN has been successfully added to your 
